Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Glaucoma Specialists (US)(?)

Council Members in this Study Group: 190

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Paul Chen, MD, Ophthalmologist, North County Laser Eye AssociatesPaul Chen, MD
Ophthalmologist
North County Laser Eye Associates

Paul Chen, MD, is an Ophthalmologist at North County Laser Eye Associates in San Diego County, California. He provides comprehensive eye care with a focus on cataracts, glaucoma, eyelid enhancements, and laser vision correction. Dr. Chen has expertise in the latest medical and surgical techniques such...

Barry Schechter, MD, Director of Corneal and External Diseases, Florida Eye Microsurgical Institute, Inc. Barry Schechter, MD
Director of Corneal and External Diseases
Florida Eye Microsurgical Institute, Inc.

Barry Schechter, MD, is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Dr. Schechter's practice involves diseases of the ocular surface including dry eyes, allergies, infection; the latest in corneal, refractive, and cataract surgery, and glaucoma....

Jeffrey Marx, MD, Chairman of the Department of Ophthalmology , Lahey Clinic IncJeffrey Marx, MD
Chairman of the Department of Ophthalmology
Lahey Clinic Inc

Jeffrey Marx, MD, is a Chairman of the Department of Ophthalmology at the Lahey Clinic in Burlington and Associate Clinical Professor of Ophthalmology at Tufts University School of Medicine, Massachusetts. Dr Marx specializes in medical and surgical diseases of the retina including diabetic eye care,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Laser is better than Steroids in the Management of Diabetic Macular Edema. | 09-04-2008
Author: GLG Expert Contributor

This Phase III Clinical Trial clearly shows that focal grid laser is better than steroids in the management of Diabetic Macular Edema (DME).  This reaffirms laser as the current gold standard in the management of DME and casts doubts on numerous treatment modalities in the pipeline that use steroids...

This should be a significant advance. | 06-05-2008
Author: GLG Expert Contributor

This new lens represents a marriage of two important technologies in modern contact lens use; oxygen trasmissibility and convenience in wearing. This has the potential to become a significant portion of the contact lens market.

LASIK IS AN EXCELLENT PROCEDURE FOR THE APPROPRIATE CANDIDATES | 05-07-2008
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor

The FDA report and scrutiny of LASIK complaints reveals what consientious LASIK surgeons have known for years:  Not everyone who walks through your doors is a good lasik candidate and you should not laser everyone.  About 1 out of 4 patients that consider lasik are actually good candidates...

Ex-PRESS Shunt (Optonol) making Strides for Surgical Managment of Glaucoma | 04-14-2008
Author: GLG Expert Contributor

A new model of the increasing popular Ex-Press Shunt is quite effective in an early study.  Its is quite safe and effective; and simpler substitute for trabeculectomy.  It could be the first line  in the surgical management of glaucoma.

Alcon (ACL) reports Promising Results for Unique Glaucoma Medication. | 04-14-2008
Author: GLG Expert Contributor

Alcon (ACL) reported positive interim results for their injectable medication for glaucoma.  A single injection of anecortave acetate  resulted in control of IOP at the three month follow up.  This could be a promising medication for IOP control in glaucoma.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Physician - Director
  • President
  • Partner
  • Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-05T09:46:13.947